3 news items
Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
COGT
23 May 24
in the biopharmaceutical industry with an impressive track record in commercial strategy, including several successful product launches. At Cogent, he will be responsible
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting
COGT
23 May 24
, future plans and strategies, our clinical results, the rate of enrollment in our clinical trials and other future conditions. New risks and uncertainties
Cogent Biosciences Reports First Quarter 2024 Financial Results
COGT
7 May 24
the future of our business, future plans and strategies, our clinical results, the rate of enrollment in our clinical trials and other future conditions. New
- Prev
- 1
- Next